Edaravone and Caffeinol are Neuroprotective After Transient Middle Cerebral Artery Occlusion in Rats

Journal Title: Journal of Neurological Sciences-Turkish - Year 2005, Vol 22, Issue 4

Abstract

Background: Edaravone and Caffeinol are two potential stroke treatments. Their mechanisms of action are different. We aimed to confirm the benefit of Edaravone in our stroke model, and explore the effect of combining them together. Methods: Long-Evans rats with transient middle cerebral artery occlusion were assigned to one of 7 groups: (1) Edaravone vehicle, (2) Caffeinol vehicle, (3) Caffeinol; caffeine (10 mg/kg) + ethanol (0.32 g/kg) intravenously (iv) X 2 hours, (4) Edaravone 3 mg/kg bolus iv, and subcutaneously (sc) X 1 after 30 min, (5) Group 4 with additional sc Edaravone on days 1 and 2, (6) Edaravone + Caffeinol; combining groups 3 and 5, but Edaravone delayed until after the Caffeinol infusion completed, (7) Delayed Edaravone; Edaravone as in group 6. Three days later, neurological deficit (NDS) and lesion volume were measured. Results: Caffeinol and Edaravone reduced NDS by 29% (p<0.05) and 43% (p<0.001), and cortical lesion volume by 43% (p<0.001) and 46% (p<0.001) respectively. Repeating Edaravone provided no added benefit, and delaying Edaravone was less effective. Combining Edaravone + Caffeinol provided 65% cortical protection (p<0.001), 32% in striatum (p<0.01), and decreased NDS by 50% (p<0.001). Compared to Caffeinol or Edaravone alone, Edaravone + Caffeinol reduced NDS by 30% and 43% (p<0.05), cortical infarction by 39% and 54% (p<0.05), and sub-cortical infarction by 20% and 25% (p<0.05) respectively. Conclusion: Both Edaravone and Caffeinol reduce cortical infarction and neurological deficits. Combining Edaravone with Caffeinol provides better protection. Edaravone and Caffeinol, and their combination, warrant further evaluation as potentially effective stroke treatments.

Authors and Affiliations

Xiurong ZHAO, Jaroslaw ARONOWSKI, Guang-Hua SUN, Jie ZHANG, Roger STRONG, Yujian ZHANG, James GROTTA

Keywords

Related Articles

Prognostic Factors in Metastatic Brain Tumors: Study of 62 Patients

Background: Brain metastases are the major cause of morbidity and mortality in patients with cancer. Variety of clinical and autopsy studies showed that brain metastases develop at 15%-45% of all cancer patients during t...

Role of Nitric Oxide in Domoic Acid Induced Hippocampal Degeneration

We used a mouse model of domoic acid (DA)-induced temporal lobe epilepsy to determine if nitric oxide (NO) has anticonvulsant properties. The protective effects of NO were assessed using acute and chronic doses of DA (ip...

Spinal Leptomeningeal Metastasis Of Cerebral Glioblastoma Multiforme In A Child

The spreading of cerebral glioblastoma multiforme into the spinal canal and causing clinical symptoms are seen rarely. An 11-year-old male patient was admitted to our clinic with headache. Cerebral MRI showed a contrast...

Clinical And Etiological Evaluation Of Sinus Thrombosis

Ten patients (7 female, 3 male) were evaluated between 2001January -2005 March in our clinic. Mean age was 35 (range: 23-70). Initial complaint was headache in 8 patients. Loss of consciousness and visual loss were compl...

Ligamentum Flavum Ossifikasyonu: Torakal Miyelopatinin Nadir Bir Nedeni

Ligamentum flavum ossifikasyonu nadir görülen torasik myelopati nedenlerindendir. Literatürdeki olguların çoğu Japonya'dan bildirilmiş olup bu hastalık diğer ırklarda çok nadiren görülmektedir. Bu makalede T8-9 düzeyinde...

Download PDF file
  • EP ID EP91323
  • DOI -
  • Views 69
  • Downloads 0

How To Cite

Xiurong ZHAO, Jaroslaw ARONOWSKI, Guang-Hua SUN, Jie ZHANG, Roger STRONG, Yujian ZHANG, James GROTTA (2005). Edaravone and Caffeinol are Neuroprotective After Transient Middle Cerebral Artery Occlusion in Rats. Journal of Neurological Sciences-Turkish, 22(4), 374-381. https://europub.co.uk/articles/-A-91323